— Know what they know.
Not Investment Advice

RGEN NASDAQ

Repligen Corporation
1W: -4.2% 1M: +5.1% 3M: +28.4% YTD: +10.6% 1Y: +24.6% 3Y: +12.9% 5Y: -43.8%
$181.70
+4.47 (+2.52%)
 
Weekly Expected Move ±6.0%
$160 $171 $182 $193 $203
NASDAQ · Healthcare · Medical - Instruments & Supplies · Tech Score Buy · Power 62 · $10.3B mcap · 53M float · 2.07% daily turnover · Short 70% of daily vol

Revenue Segmentation

By Product / Service

Revenue by Segment (5-Year Trend)

Income Trends

Revenue
$738M +16.4% ▲
5Y CAGR: +15.0%
Gross Profit
$348M +26.6% ▲
5Y CAGR: +12.3%
Operating Income
$60M +269.7% ▲
5Y CAGR: -6.0%
Net Income
$49M +291.6% ▲
5Y CAGR: -4.0%
EPS (Diluted)
$0.86 +287.0% ▲
5Y CAGR: -5.0%
EBITDA
$164M +104.7% ▲
5Y CAGR: +10.8%

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
Revenue$671M$802M$632M$634M$738M
YoY Growth+83.1%+19.5%-21.1%+0.3%+16.4%
Cost of Revenue$279M$346M$354M$360M$391M
Gross Profit$391M$456M$278M$275M$348M
Gross Margin58.3%56.9%44.0%43.3%47.1%
R&D Expenses$34M$44M$43M$43M$54M
SG&A Expenses$184M$216M$219M$263M$291M
Operating Expenses$224M$231M$231M$310M$288M
Operating Income$167M$225M$48M-$35M$60M
Operating Margin24.9%28.0%7.5%-5.5%8.1%
Interest Expense$13M$3M$10M$23M$23M
Income Before Tax$154M$219M$57M-$27M$62M
Tax Expense$25M$33M$21M-$2M$13M
Net Income$128M$186M$36M-$26M$49M
Net Margin19.1%23.2%5.6%-4.0%6.6%
EPS (Diluted)$2.24$3.24$0.63$-0.46$0.86
EBITDA$203M$277M$145M$80M$164M
Shares Outstanding57M57M56M56M57M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms